Bibliography
- Jemal A, Siegel R, Ward E, Cancer statistics 2008. CA Cancer J Clin 2008;58:71-96
- FIGO. Annual report on the results of treatment in gynecologic cancer. Int J Gynaecol Obstet 1989;28:189-93
- Cho H, Kim YT, Kim JH. Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy. Acta Obstet Gynecol Scand 2010;89(2):175-81
- Mariani A, Dowdy SC, Cliby WA, Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109:11-8
- Walsh CS, Karlan BY. Lymphadenectomy's role in early endometrial cancer: prognostic or therapeutic? J Natl Cancer Inst 2008;100:1660-1
- Kitchener H, Swart AM, Qian Q, ; ASTEC Study Group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36
- Resnick KE, Cohn DE, Fowler JM. Role of lymphadenectomy in the staging of endometrial cancer. Nat Rev Clin Oncol 2009;6:382-4
- Oonk MH, van de Nieuwenhof HP, de Hullu JA, van der Zee AG. The role of sentinel node biopsy in gynecological cancer: a review. Curr Opin Oncol 2009;21:425-32
- Boronow RC. Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge–a personal perspective. Gynecol Oncol 1997;66:179-89
- Boronow RC. Endometrial cancer and lymph node surgery: the spins continue–a case for reason. Gynecol Oncol 2008;111:3-6
- Creasman WT, Odicino F, Maisonneuve P, Carcinoma of the corpus uteri. Int J Gynaecol Obstet 2003;83:79-118
- Creasman WT, Odicino F, Maisonneuve P, Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95:S105-43
- Boronow RC, Morrow CP, Creasman WT, Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-32
- Kinkel K, Kaji Y, Yu KK, Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-8
- Frei KA, Kinkel K, Bonel HM, Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging–a meta-analysis and Bayesian analysis. Radiology 2000;216:444-9
- Koyama T, Tamai K, Togashi K. Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 2007;17:2009-19
- Kinkel K, Forstner R, Danza FM, ; European Society of Urogenital Imaging. Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 2009;19:1565-74
- Lien HH, Blomlie V, Tropé C, Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium. AJR Am J Roentgenol 1991;157:1221-3
- Hricak H, Hamm B, Semelka RC, Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging. Radiology 1991;181:95-106
- Hirano Y, Kubo K, Hirai Y, Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms. Radiographics. 1992;12:243-56
- Hwang JH, Lee NW, Lee KW, Lee JK. Magnetic resonance imaging for assessment of deep endometrial invasion for patients with endometrial carcinoma. Aust NZ J Obstet Gynaecol 2009;49:537-41
- Nagar H, Dobbs S, McClelland HR, The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. Gynecol Oncol 2006;103:431-4
- Kang WD, Kim CH, Cho MK, Lymphadenectomy for low-risk endometrial cancer based on preoperative and intraoperative assessments. Int J Gynecol Cancer 2009;19:657-61
- Harry VN, Deans H, Ramage E, Magnetic resonance imaging in gynecological oncology. Int J Gynecol Cancer 2009;19:186-93
- Manfredi R, Mirk P, Maresca G, Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 2004;231:372-8
- Nakao Y, Yokoyama M, Hara K, MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol 2006;102:343-7
- Ortashi O, Jain S, Emannuel O, Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol 2008;137:232-5
- Savelli L, Ceccarini M, Ludovisi M, Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol 2008;31:560-6
- Shen SH, Chiou YY, Wang JH, Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008;190:481-8
- Tamai K, Koyama T, Saga T, Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007;26:682-7
- Fujii S, Matsusue E, Kigawa J, Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 2008;18:384-9
- Rechichi G, Galimberti S, Signorelli M, Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 2010;20(3):754-62
- Torricelli P, Ferraresi S, Fiocchi F, 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. AJR Am J Roentgenol 2008;190:489-95
- Lin G, Ng KK, Chang CJ, Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging–initial experience. Radiology 2009;250:784-92
- Hori M, Kim T, Murakami T, MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: comparison with imaging at 1.5 T. J Magn Reson Imaging. 2009;30:621-30
- Yoshida Y, Kurokawa T, Sawamura Y, The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer. Gynecol Oncol 2007;104:764-6
- Tsujikawa T, Yoshida Y, Mori T, Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET–initial experience. Radiology 2008;248:599-605
- Tsujikawa T, Yoshida Y, Kudo T, Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET. J Nucl Med 2009;50:1598-604
- Cabrita S, Rodrigues H, Abreu R, Magnetic resonance imaging in the preoperative staging of endometrial carcinoma. Eur J Gynecolo Oncol 2008;29:135-7
- Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests for lymph node status in primary endometrial cancer [review]. BMC Womens Health 2008;8:8
- Maffione AM, Piva M, Tsamita CS, Positron-emission tomography in gynaecologic malignancies. Arch Gynecol Obstet 2009;280:521-8
- Horowitz NS, Dehdashti F, Herzog TJ, Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 2004;95:546-51
- Chao A, Chang TC, Ng KK, 18F-FDG PET in the management of endometrial cancer. Eur J Nucl Med Mol Imaging 2006;33:36-44
- Suzuki R, Miyagi E, Takahashi N, Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer. Int J Gynecol Cancer 2007;17:890-6
- Park JY, Kim EN, Kim DY, Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 2008;108:486-92
- Kitajima K, Murakami K, Yamasaki E, Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol 2008;190:1652-8
- Signorelli M, Guerra L, Buda A, Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases. Gynecol Oncol 2009;115:231-5
- Kitajima K, Murakami K, Yamasaki E, Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol 2009;19:1529-36
- Vassallo P, Matei C, Heston WD, AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994;193:501-506
- Narayanan P, Iyngkaran T, Sohaib SA, Magnetic resonance lymphography: a novel technique for lymph node assessment in gynecologic malignancies. Cancer Biomark 2009;5:81-8
- Rockall AG, Sohaib SA, Harisinghani MG, Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005;23:2813-21
- Choi SH, Kim KH, Moon WK, Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model. J Magn Reson Imaging 2010;31:134-41
- Choi SH, Moon WK, Hong JH, Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model. Radiology 2007;242:137-43
- American College of Radiology Investigative Network. Available from: http://www.acrin.org